Attempts to develop effective alternatives to viral vectors for gene delivery are continually frustrated by difficulties of combining extracellular stability of the new vector with ready availability ...
Biora's BioJet systemic oral therapeutics platform uses an ingestible capsule for needle-free, oral delivery of large molecules designed to achieve systemic bioavailability and replace injection for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results